Office-use compounding in Oregon

What the rule requires in practice

Each item carries a confidence level. Verbatim rule text is high confidence; a reading of how two provisions interact, or a source that could not be re-verified, is not.

The silence is a 2026 drafting choice with a date on itHigh confidence

Oregon repealed its entire compounding division on 17 June 2026 and replaced it the same day. The new division applies to sterile and non-sterile compounding for humans and animals alike, and it creates exactly one waiver of patient-specificity: veterinary. The phrase "office use" appears zero times in the adopting order.That distinction matters commercially. A legacy gap invites the argument that nobody has considered the question. A state that rewrote the whole division this year, created one waiver, and did not create a human one has considered it.

Never cite the old divisionHigh confidence

Everything numbered in the repealed division went on 17 June 2026. A widely used third-party mirror of Oregon rules still serves a snapshot from May 2025 and is therefore still publishing repealed law today. Use the state’s own rules database, and treat any Oregon citation to the old numbering as evidence the source has not been re-pulled since the rewrite.

Reclassification is not prohibition, and the difference is the operative pointHigh confidence

Oregon does not say a pharmacy may not do this. It says that doing it makes you a manufacturer, which is a different credential with a different fee, a different renewal cycle and — for a Class II registration — a federal-compliance condition attached. The route exists; it is simply not the 503A pharmacy route.

The nuclear limb, and why it is not cleanMedium confidence

A nuclear pharmacy may furnish radiopharmaceuticals for office use to the practitioners named in that rule, and that rule carries the only office-use label legend Oregon prescribes. But the rule dates from 1994 and the 2026 rewrite imposes a chapter-wide patient-specific definition. Which governs is unresolved on the face of the rules.Do not present the nuclear limb as a settled carve-out. It is an older rule that the newer chapter did not expressly reconcile, and no board ruling addressing the tension was located.

Quantity and labellingHigh confidence

No numeric cap exists anywhere: "inordinate" and "reasonable quantity" return zero across all four hundred and sixty-eight rules in the chapter. The only quantity phrase is "minimal quantities", undefined, and it sits in the wholesale division rather than the compounding one. There is no general label legend — the single legend is radiopharmaceutical-only.

The 5% clause contains the literal words "for office use", and it is the wrong doorHigh confidence

OAR 855-065-0005(18)(b) exempts the sale of minimal quantities of a prescription drug by retail or institutional pharmacies to licensed practitioners for office use. It is qualitative, undefined and never quantified by rule — and it exempts a transaction from wholesale licensure in one division while doing nothing at all about the division that independently requires manufacturer registration for non-patient-specific compounded supply. Escaping one licence walks you into another.This is the clause most likely to be quoted at an Oregon prescriber, because it contains the exact phrase a reader is searching for. It is in the wholesale division for a reason.

Entity or person — ownership-complete, so neither usual trap firesHigh confidence

Oregon registers the outlet rather than the person, and separately forces disclosure of the company behind it. So the question that splits other states — whether a business entity can hold the authority — does not arise in the same form: the site is what is registered, and its ownership is on the record.

Last change, and four dated aheadHigh confidence

The rewrite landed 17 June 2026. Two temporary rules expire and revert unless made permanent — one on the dispensing-practitioner outlet on 13 December 2026, one on fees on 9 February 2027. Mobile pharmacy licensure becomes operative 1 January 2027 and contains no compounding provisions at all, which is worth stating so nobody over-reads it.The one worth planning around is 1 November 2027: from that date a non-resident drug outlet preparing compounded products must have been inspected against the USP standards, or hold accreditation from one of four named accreditors granted within the preceding two years, before licensure or renewal. It is a hard, dated, named requirement aimed squarely at out-of-state compounders.

Oregon at a glance

Receiving 503B office stock in Oregon

Oregon licenses these facilities as manufacturers under a class of drug outlet, so the term a reader searches for returns almost nothing useful. The receiving practice needs a credential only if it dispenses, and prescribers are expressly exempt from the state controlled-substance registration that does exist.

Everything above this heading answers the supply question: may a state-licensed 503A pharmacy ship non-patient-specific stock? This section answers the other half. Registration with FDA under section 503B is a federal exemption from federal law and preempts no state licensing scheme, so it is never the whole answer on its own — a state credential is the norm rather than the exception, it is not always issued by the board of pharmacy, and in some states the category you would search for does not exist. What Oregon asks for is set out below, including where we could not establish it.

What the 503B must hold to ship inHigh confidence

A Manufacturer drug outlet registration, Class II, at $735 a year, expiring 30 September, per location. The literal term "outsourcing facility" appears only three times across the whole chapter and never as the name of the credential.The Class II registration carries a federal-compliance condition in terms — it requires compliance with the federal outsourcing-facility manufacturing requirements — which converts a federal breach into a state one.

Does your practice need a permit?High confidence

Only if it dispenses. A Dispensing Practitioner Drug Outlet registration costs $140 a year and carries a seventy-two-hour-supply safe harbour. A practice that only administers needs nothing.

Administer vs dispenseHigh confidence

This is the cleanest administer-versus-dispense line in the file: possession and administration trigger no credential, dispensing triggers a named outlet registration, and the safe harbour is measured in hours of supply rather than in dollars or units.

Scheduled (controlled) stockHigh confidence

A state registration exists but prescribers are exempt from it by statute, and there is no practitioner fee line in the fee rule. For a prescriber the federal registration is the whole requirement.This is a distinct shape from the states that have no state registration at all. Oregon has one; it simply does not reach prescribers. Claiming an Oregon prescriber needs it is claiming a credential that does not apply.

How to check a facility’s credential before you order is set out in how to place an office-use order.

What this page does not establish

• The tension between the 1994 nuclear rule and the 2026 chapter-wide patient-specific definition is unresolved on the face of the rules, and we located no board declaratory ruling addressing it. The nuclear limb is not presented here as clean.
• We did not survey pending rulemaking notices filed but not yet adopted. The state’s filings search is script-gated and its positive control failed, so the change list behind this page was built from the history lines of every rule in the chapter — complete for adopted filings, blind to open notices. A compounding notice filed after the June 2026 rewrite would not appear here.
• Whether the surviving nuclear permission would itself survive a challenge under the newer chapter is a question of Oregon administrative law that this page does not research.
• We searched no case law or attorney-general opinions for this state, and search engines were unavailable when it was researched. Read nothing into that silence — it means we have not looked, not that nothing is there.